Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto C S Costa

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
CNS Drugs|July 4, 2013
Prospects for improving brain function in individuals with Down syndromeAlberto C S Costa, Jonah J Scott-McKean
Learning & Memory (Cold Spring Harbor, N.Y.)|November 22, 2011
Exaggerated NMDA mediated LTD in a mouse model of Down syndrome and pharmacological rescuing by memantineJonah J Scott-McKean, Alberto C S Costa
Frontiers in Molecular Neuroscience|March 24, 2022
Bio-Mimicking, Electrical Excitability Phenomena Associated With Synthetic Macromolecular Systems: A Brief Review With Connections to the Cytoskeleton and Membraneless OrganellesGary E Wnek, Alberto C S Costa, Susan K Kozawa
Basic & Clinical Pharmacology & Toxicology|May 31, 2017
Pharmacokinetic Properties of Memantine after a Single Intraperitoneal Administration and Multiple Oral Doses in Euploid Mice and in the Ts65Dn Mouse Model of Down's SyndromeDaniella B Victorino, Ilya R Bederman, Alberto C S Costa
Neuroreport|May 19, 2006
Hypothermic responses to 8-OH-DPAT in the Ts65Dn mouse model of Down syndromeMelissa R Stasko, Jonah J Scott-McKean, Alberto C S Costa
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 19, 2007
Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning testAlberto C S Costa, Jonah J Scott-McKean, Melissa R Stasko
Behavioural Brain Research|September 2, 2009
Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6b(rd1)Alberto C S Costa, Melissa R Stasko, Cecilia Schmidt, et al.
Journal of Neurogenetics|March 12, 2011
Machine learning methods predict locomotor response to MK-801 in mouse models of down syndromeCao D Nguyen, Alberto C S Costa, Krzysztof J Cios, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 27, 2005
G-protein-gated potassium (GIRK) channels containing the GIRK2 subunit are control hubs for pharmacologically induced hypothermic responsesAlberto C S Costa, Melissa R Stasko, Markus Stoffel, et al.
Experimental Neurology|April 21, 2006
Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndromeSarah Clark, Jennifer Schwalbe, Melissa R Stasko, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
CNS Drugs|July 4, 2013
Prospects for improving brain function in individuals with Down syndromeAlberto C S Costa, Jonah J Scott-McKean
Learning & Memory (Cold Spring Harbor, N.Y.)|November 22, 2011
Exaggerated NMDA mediated LTD in a mouse model of Down syndrome and pharmacological rescuing by memantineJonah J Scott-McKean, Alberto C S Costa
Frontiers in Molecular Neuroscience|March 24, 2022
Bio-Mimicking, Electrical Excitability Phenomena Associated With Synthetic Macromolecular Systems: A Brief Review With Connections to the Cytoskeleton and Membraneless OrganellesGary E Wnek, Alberto C S Costa, Susan K Kozawa
Basic & Clinical Pharmacology & Toxicology|May 31, 2017
Pharmacokinetic Properties of Memantine after a Single Intraperitoneal Administration and Multiple Oral Doses in Euploid Mice and in the Ts65Dn Mouse Model of Down's SyndromeDaniella B Victorino, Ilya R Bederman, Alberto C S Costa
Neuroreport|May 19, 2006
Hypothermic responses to 8-OH-DPAT in the Ts65Dn mouse model of Down syndromeMelissa R Stasko, Jonah J Scott-McKean, Alberto C S Costa
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 19, 2007
Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning testAlberto C S Costa, Jonah J Scott-McKean, Melissa R Stasko
Behavioural Brain Research|September 2, 2009
Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6b(rd1)Alberto C S Costa, Melissa R Stasko, Cecilia Schmidt, et al.
Journal of Neurogenetics|March 12, 2011
Machine learning methods predict locomotor response to MK-801 in mouse models of down syndromeCao D Nguyen, Alberto C S Costa, Krzysztof J Cios, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 27, 2005
G-protein-gated potassium (GIRK) channels containing the GIRK2 subunit are control hubs for pharmacologically induced hypothermic responsesAlberto C S Costa, Melissa R Stasko, Markus Stoffel, et al.
Experimental Neurology|April 21, 2006
Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndromeSarah Clark, Jennifer Schwalbe, Melissa R Stasko, et al.
Pageof 5